2022.04.19

Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets

This work is published on Pharmaceutics in January, 2022. It is a cooperation with Prof. Hsueh-Fen Juan from Department of Life Science and Institute of Molecular and Cellular Biology, NTU.

The BSL-3 Research and Analysis Laboratory helped to determine the EC50 of these selected compounds against authentic SARS-CoV-2 variants via plaque reduction assay.